Compound details
Kopsidasine
| Compound ID | CDAMM00602 |
|---|---|
| Common name | Kopsidasine | IUPAC name | dimethyl 21-hydroxy-6-methoxy-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3(8),4,6,17-tetraene-2,18-dicarboxylate |
| Molecular formula | C24H28N2O6 |
| Retention time | 13.29 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 441.204 | Theoretical mz | 441.202 |
| Error | 4.59 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.9779 |
| Inchi key | DCDARNHBHIXVJO-JFDNOCKINA-N |
|---|---|
| Smiles | O=C(OC)C1=CC23CCCN4CCC5(C6=CC(OC)=CC=C6N(C(=O)OC)C15CC2)C43O |
| Superclass | Alkaloids and derivatives |
| Class | Aspidofractine alkaloids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P43681 | CHRNA4 | Neuronal acetylcholine receptor; alpha4/beta2 | T70967 | SwissTargetPrediction |
| P08173 | CHRM4 | Muscarinic acetylcholine receptor M4 | T20709 | SwissTargetPrediction |
| P08912 | CHRM5 | Muscarinic acetylcholine receptor M5 | T79961 | SwissTargetPrediction |
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P11229 | CHRM1 | Muscarinic acetylcholine receptor M1 | T28893 | SwissTargetPrediction |
| P20309 | CHRM3 | Muscarinic acetylcholine receptor M3 | T67684 | SwissTargetPrediction |
| Q99720 | SIGMAR1 | Sigma opioid receptor | T46360 | SwissTargetPrediction |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SwissTargetPrediction |
| P06239 | LCK | Tyrosine-protein kinase LCK | T12499 | SwissTargetPrediction |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction |
| P27487 | DPP4 | Dipeptidyl peptidase IV | T31391 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| P31645 | SLC6A4 | Serotonin transporter (by homology) | T27812 | SwissTargetPrediction |
| Q15118 | PDK1 | Pyruvate dehydrogenase kinase isoform 1 | T20891 | SwissTargetPrediction |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SwissTargetPrediction |
| P42785 | PRCP | Lysosomal Pro-X carboxypeptidase | T20371 | SwissTargetPrediction |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SwissTargetPrediction |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SwissTargetPrediction |
| Q01959 | SLC6A3 | Dopamine transporter | T55959 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| P18825 | ADRA2C | Adrenergic receptor alpha-2 | T01777 | SwissTargetPrediction |
| P25100 | ADRA1D | Alpha-1d adrenergic receptor | T53381 | SwissTargetPrediction |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P36888 | FLT3 | Tyrosine-protein kinase receptor FLT3 | T74312 | SwissTargetPrediction |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | T85799 | SwissTargetPrediction |
| Q9P1W9 | PIM2 | Serine/threonine-protein kinase PIM2 | T07279 | SwissTargetPrediction |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SwissTargetPrediction |
| P24723 | PRKCH | Protein kinase C eta | T40149 | SwissTargetPrediction |
| Q16850 | CYP51A1 | Cytochrome P450 51 (by homology) | T32972 | SwissTargetPrediction |
| P35348 | ADRA1A | Alpha-1a adrenergic receptor | T92609 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| O96017 | CHEK2 | Serine/threonine-protein kinase Chk2 | T28713 | SwissTargetPrediction |
| P41743 | PRKCI | Protein kinase C iota | T83174 | SwissTargetPrediction |
| P05771 | PRKCB | Protein kinase C beta | T40276 | SwissTargetPrediction |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SwissTargetPrediction |
| Q5S007 | LRRK2 | Leucine-rich repeat serine/threonine-protein kinase 2 | T08123 | SwissTargetPrediction |
| P10721 | KIT | Stem cell growth factor receptor | T57700 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| O00444 | PLK4 | Serine/threonine-protein kinase PLK4 | T71374 | SwissTargetPrediction |
| P49759 | CLK1 | Dual specificty protein kinase CLK1 | T46685 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SEA |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SwissTargetPrediction |
| Q05655 | PRKCD | Protein kinase C delta | T44861 | SwissTargetPrediction |
| P23443 | RPS6KB1 | Ribosomal protein S6 kinase 1 | T94479 | SwissTargetPrediction |
| Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | T98225 | SwissTargetPrediction |
| P09619 | PDGFRB | Platelet-derived growth factor receptor beta | T59102 | SwissTargetPrediction |
| P11362 | FGFR1 | Fibroblast growth factor receptor 1 | T47101 | SwissTargetPrediction |
| P34995 | PTGER1 | Prostanoid EP1 receptor | T15497 | SwissTargetPrediction |
| P50613 | CDK7 | Cyclin-dependent kinase 7 | T58449 | SwissTargetPrediction |
| P49760 | CLK2 | Dual specificity protein kinase CLK2 | T73725 | SwissTargetPrediction |
| Q07912 | TNK2 | Tyrosine kinase non-receptor protein 2 | T63220 | SwissTargetPrediction |
| P31751 | AKT2 | Serine/threonine-protein kinase AKT2 | T94621 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| O14976 | GAK | Serine or threonine-protein kinase GAK | T00043 | SwissTargetPrediction |
| P68400 | CSNK2A1 | Casein kinase II alpha | T51565 | SwissTargetPrediction |
| P19784 | CSNK2A2 | Casein kinase II alpha (prime) | T80526 | SwissTargetPrediction |
| Q9UQM7 | CAMK2A | CaM kinase II alpha | T18299 | SwissTargetPrediction |
| P15056 | BRAF | Serine/threonine-protein kinase B-raf | T99089 | SwissTargetPrediction |
| P80192 | MAP3K9 | Mitogen-activated protein kinase kinase kinase 9 | T19760 | SwissTargetPrediction |
| O75582 | RPS6KA5 | Ribosomal protein S6 kinase alpha 5 | T50224 | SwissTargetPrediction |
| P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha 3 | T03279 | SwissTargetPrediction |
| P08631 | HCK | Tyrosine-protein kinase HCK | T31406 | SwissTargetPrediction |
| Q15746 | MYLK | Myosin light chain kinase, smooth muscle | T97141 | SwissTargetPrediction |
| O43293 | DAPK3 | Death-associated protein kinase 3 | T81623 | SwissTargetPrediction |
| Q15418 | RPS6KA1 | Ribosomal protein S6 kinase alpha 1 | T83202 | SwissTargetPrediction |
| Q13237 | PRKG2 | cGMP-dependent protein kinase 2 | T23606 | SwissTargetPrediction |
| Q9UK32 | RPS6KA6 | Ribosomal protein S6 kinase alpha 6 | T95878 | SwissTargetPrediction |
| Q2M2I8 | AAK1 | Adaptor-associated kinase | T32764 | SwissTargetPrediction |
| Q7KZI7 | MARK2 | MAP/microtubule affinity-regulating kinase 2 | T01396 | SwissTargetPrediction |
| P27448 | MARK3 | Serine/threonine-protein kinase c-TAK1 | T90553 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| O96013 | PAK4 | Serine/threonine-protein kinase PAK 4 | T98293 | SwissTargetPrediction |
| Q16512 | PKN1 | Protein kinase N1 | T60003 | SwissTargetPrediction |
| Q9UQB9 | AURKC | Serine/threonine-protein kinase Aurora-C | T97592 | SwissTargetPrediction |
| Q16513 | PKN2 | Protein kinase N2 | T94197 | SwissTargetPrediction |
| Q9UQM7 | CAMK2A | CaM kinase II alpha | T18299 | SwissTargetPrediction |
| Q96SB4 | SRPK1 | Serine/threonine-protein kinase SRPK1 | T94201 | SwissTargetPrediction |
| Q9NSY1 | BMP2K | BMP-2-inducible protein kinase | T90961 | SwissTargetPrediction |
| Q15349 | RPS6KA2 | Ribosomal protein S6 kinase alpha 2 | T28043 | SwissTargetPrediction |
| Q9UKE5 | TNIK | TRAF2- and NCK-interacting kinase | T72534 | SwissTargetPrediction |
| Q9H2G2 | SLK | Serine/threonine-protein kinase 2 | T57307 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T70967 | DI0029 | Aneurysm/dissection | [ICD-11: BD50] | P43681 | CHRNA4 |
| T70967 | DI0191 | Hypertensive crisis | [ICD-11: BA03] | P43681 | CHRNA4 |
| T70967 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P43681 | CHRNA4 |
| T20709 | DI0037 | Asthma | [ICD-11: CA23] | P08173 | CHRM4 |
| T20709 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | P08173 | CHRM4 |
| T20709 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08173 | CHRM4 |
| T20709 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P08173 | CHRM4 |
| T20709 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08173 | CHRM4 |
| T79961 | DI0002 | Abnormal micturition | [ICD-11: MF50] | P08912 | CHRM5 |
| T79961 | DI0032 | Anterior uveitis | [ICD-11: 9A96] | P08912 | CHRM5 |
| T79961 | DI0034 | Appearance/behaviour symptom | [ICD-11: MB23] | P08912 | CHRM5 |
| T79961 | DI0037 | Asthma | [ICD-11: CA23] | P08912 | CHRM5 |
| T79961 | DI0061 | Brain disease | [ICD-11: 8C70-8E61] | P08912 | CHRM5 |
| T79961 | DI0071 | Central and peripheral nervous disease | [ICD-11: 8A04-8E7Z] | P08912 | CHRM5 |
| T79961 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P08912 | CHRM5 |
| T79961 | DI0093 | Cognition symptoms/signs/clinical symptom | [ICD-11: MB21] | P08912 | CHRM5 |
| T79961 | DI0105 | Cough | [ICD-11: MD12] | P08912 | CHRM5 |
| T79961 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P08912 | CHRM5 |
| T79961 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P08912 | CHRM5 |
| T79961 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P08912 | CHRM5 |
| T79961 | DI0158 | Gastritis | [ICD-11: DA42] | P08912 | CHRM5 |
| T79961 | DI0162 | General examination | [ICD-11: QA00] | P08912 | CHRM5 |
| T79961 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08912 | CHRM5 |
| T79961 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08912 | CHRM5 |
| T79961 | DI0208 | Infectious gastroenteritis/colitis | [ICD-11: 1A40] | P08912 | CHRM5 |
| T79961 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P08912 | CHRM5 |
| T79961 | DI0307 | Nystagmus | [ICD-11: 9C84] | P08912 | CHRM5 |
| T79961 | DI0315 | Oesophagus motility disorder | [ICD-11: DA21] | P08912 | CHRM5 |
| T79961 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P08912 | CHRM5 |
| T79961 | DI0329 | Pancreatitis | [ICD-11: DC31-DC34] | P08912 | CHRM5 |
| T79961 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P08912 | CHRM5 |
| T79961 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08912 | CHRM5 |
| T79961 | DI0338 | Polyuria | [ICD-11: MF55] | P08912 | CHRM5 |
| T79961 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P08912 | CHRM5 |
| T79961 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P08912 | CHRM5 |
| T79961 | DI0424 | Urgency | [ICD-11: N.A.] | P08912 | CHRM5 |
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T28893 | DI0001 | Abdominal pelvic pain | [ICD-11: MD81] | P11229 | CHRM1 |
| T28893 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P11229 | CHRM1 |
| T28893 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P11229 | CHRM1 |
| T28893 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | P11229 | CHRM1 |
| T28893 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P11229 | CHRM1 |
| T28893 | DI0157 | Gastric ulcer | [ICD-11: DA60] | P11229 | CHRM1 |
| T28893 | DI0166 | Glaucoma | [ICD-11: 9C61] | P11229 | CHRM1 |
| T28893 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P11229 | CHRM1 |
| T28893 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P11229 | CHRM1 |
| T28893 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P11229 | CHRM1 |
| T28893 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P11229 | CHRM1 |
| T28893 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P11229 | CHRM1 |
| T67684 | DI0037 | Asthma | [ICD-11: CA23] | P20309 | CHRM3 |
| T67684 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P20309 | CHRM3 |
| T67684 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P20309 | CHRM3 |
| T67684 | DI0166 | Glaucoma | [ICD-11: 9C61] | P20309 | CHRM3 |
| T67684 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P20309 | CHRM3 |
| T67684 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P20309 | CHRM3 |
| T67684 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P20309 | CHRM3 |
| T67684 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P20309 | CHRM3 |
| T67684 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P20309 | CHRM3 |
| T67684 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P20309 | CHRM3 |
| T46360 | DI0105 | Cough | [ICD-11: MD12] | Q99720 | SIGMAR1 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T12499 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P06239 | LCK |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T31391 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P27487 | DPP4 |
| T31391 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P27487 | DPP4 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T27812 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P31645 | SLC6A4 |
| T27812 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P31645 | SLC6A4 |
| T27812 | DI0087 | Chronic pain | [ICD-11: MG30] | P31645 | SLC6A4 |
| T27812 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P31645 | SLC6A4 |
| T27812 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P31645 | SLC6A4 |
| T27812 | DI0105 | Cough | [ICD-11: MD12] | P31645 | SLC6A4 |
| T27812 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P31645 | SLC6A4 |
| T27812 | DI0264 | Migraine | [ICD-11: 8A80] | P31645 | SLC6A4 |
| T27812 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P31645 | SLC6A4 |
| T27812 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P31645 | SLC6A4 |
| T27812 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P31645 | SLC6A4 |
| T20891 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q15118 | PDK1 |
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T55959 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | Q01959 | SLC6A3 |
| T55959 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q01959 | SLC6A3 |
| T55959 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | Q01959 | SLC6A3 |
| T55959 | DI0290 | Narcolepsy | [ICD-11: 7A20] | Q01959 | SLC6A3 |
| T55959 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q01959 | SLC6A3 |
| T55959 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q01959 | SLC6A3 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T01777 | DI0166 | Glaucoma | [ICD-11: 9C61] | P18825 | ADRA2C |
| T01777 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P18825 | ADRA2C |
| T01777 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P18825 | ADRA2C |
| T01777 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18825 | ADRA2C |
| T01777 | DI0310 | Ocular disease | [ICD-11: N.A.] | P18825 | ADRA2C |
| T01777 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18825 | ADRA2C |
| T53381 | DI0166 | Glaucoma | [ICD-11: 9C61] | P25100 | ADRA1D |
| T53381 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P25100 | ADRA1D |
| T53381 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P25100 | ADRA1D |
| T53381 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P25100 | ADRA1D |
| T53381 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P25100 | ADRA1D |
| T53381 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P25100 | ADRA1D |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T74312 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P36888 | FLT3 |
| T74312 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P36888 | FLT3 |
| T74312 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P36888 | FLT3 |
| T74312 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P36888 | FLT3 |
| T74312 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P36888 | FLT3 |
| T74312 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P36888 | FLT3 |
| T74312 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P36888 | FLT3 |
| T74312 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P36888 | FLT3 |
| T85799 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11802 | CDK4 |
| T85799 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11802 | CDK4 |
| T85799 | DI0351 | Psoriasis | [ICD-11: EA90] | P11802 | CDK4 |
| T07279 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9P1W9 | PIM2 |
| T07279 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9P1W9 | PIM2 |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T40149 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P24723 | PRKCH |
| T32972 | DI0209 | Infectious meningitis | [ICD-11: 1D01] | Q16850 | CYP51A1 |
| T32972 | DI0289 | Nail/perionychium infection | [ICD-11: EE12] | Q16850 | CYP51A1 |
| T32972 | DI0316 | Onchocerciasis | [ICD-11: 1F6A] | Q16850 | CYP51A1 |
| T92609 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P35348 | ADRA1A |
| T92609 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P35348 | ADRA1A |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T28713 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O96017 | CHEK2 |
| T83174 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P41743 | PRKCI |
| T40276 | DI0123 | Diffuse large B-cell lymphoma | [ICD-11: 2A81] | P05771 | PRKCB |
| T40276 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P05771 | PRKCB |
| T40276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P05771 | PRKCB |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |
| T08123 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q5S007 | LRRK2 |
| T57700 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P10721 | KIT |
| T57700 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P10721 | KIT |
| T57700 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P10721 | KIT |
| T57700 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P10721 | KIT |
| T57700 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P10721 | KIT |
| T57700 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P10721 | KIT |
| T57700 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P10721 | KIT |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T71374 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O00444 | PLK4 |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T44861 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q05655 | PRKCD |
| T94479 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P23443 | RPS6KB1 |
| T94479 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P23443 | RPS6KB1 |
| T94479 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P23443 | RPS6KB1 |
| T59102 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P09619 | PDGFRB |
| T59102 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P09619 | PDGFRB |
| T59102 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09619 | PDGFRB |
| T47101 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11362 | FGFR1 |
| T47101 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P11362 | FGFR1 |
| T47101 | DI0235 | Liver cancer | [ICD-11: 2C12] | P11362 | FGFR1 |
| T47101 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P11362 | FGFR1 |
| T15497 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P34995 | PTGER1 |
| T58449 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P50613 | CDK7 |
| T58449 | DI0238 | Lung cancer | [ICD-11: 2C25] | P50613 | CDK7 |
| T58449 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P50613 | CDK7 |
| T58449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50613 | CDK7 |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T00043 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O14976 | GAK |
| T51565 | DI0104 | Coronavirus infection | [ICD-11: 1D92] | P68400 | CSNK2A1 |
| T51565 | DI0235 | Liver cancer | [ICD-11: 2C12] | P68400 | CSNK2A1 |
| T51565 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P68400 | CSNK2A1 |
| T18299 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UQM7 | CAMK2A |
| T99089 | DI0252 | Melanoma | [ICD-11: 2C30] | P15056 | BRAF |
| T19760 | DI0037 | Asthma | [ICD-11: CA23] | P80192 | MAP3K9 |
| T03279 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P51812 | RPS6KA3 |
| T31406 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P08631 | HCK |
| T97141 | DI0127 | Duodenal ulcer | [ICD-11: DA63] | Q15746 | MYLK |
| T83202 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q15418 | RPS6KA1 |
| T95878 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q9UK32 | RPS6KA6 |
| T32764 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q2M2I8 | AAK1 |
| T90553 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P27448 | MARK3 |
| T90553 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P27448 | MARK3 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T98293 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O96013 | PAK4 |
| T98293 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O96013 | PAK4 |
| T97592 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q9UQB9 | AURKC |
| T97592 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q9UQB9 | AURKC |
| T97592 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UQB9 | AURKC |
| T18299 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UQM7 | CAMK2A |
| T94201 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q96SB4 | SRPK1 |
| T28043 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q15349 | RPS6KA2 |